Drug Patents owned by Purple Biotech

1. Drug name - CONSENSI

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9662315 PURPLE BIOTECH Ameliorating drug-induced elevations in blood pressure by adjunctive use of antihypertensive drugs May, 2029

(6 years from now)

US9408837 PURPLE BIOTECH Ameliorating drug-induced elevations in blood pressure by adjunctive use of antihypertensive drugs Feb, 2030

(7 years from now)

US10925835 PURPLE BIOTECH Celecoxib and amlodipine formulation and method of making the same Jun, 2038

(15 years from now)

US10945960 PURPLE BIOTECH Celecoxib and amlodipine formulation and method of making the same Jun, 2038

(15 years from now)

US10350171 PURPLE BIOTECH Celecoxib and amlodipine formulation and method of making the same Jun, 2038

(15 years from now)

Drugs and Companies using AMLODIPINE BESYLATE; CELECOXIB ingredient

Treatment: Treatment of adult patients for whom treatment with both amlodipine for hypertension and celecoxib for osteoarthritis are appropriate

Dosage: TABLET;ORAL

More Information on Dosage
Strength Dosage Availability
EQ 2.5MG BASE;200MG TABLET;ORAL Discontinued
EQ 5MG BASE;200MG TABLET;ORAL Discontinued
EQ 10MG BASE;200MG TABLET;ORAL Discontinued

availability in other generic markets.

Click on the highlighted region to filter.